Insider sale
DYNE THERAPEUTICS, INC.
$834.6K
45.71K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 45.71K shares of DYNE THERAPEUTICS, INC. valued at approximately $834.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/27/2026ACC: 0001628280-26-027569
10% Owner
Since Dec 2022
45.71K
Shares to sell
$834.6K
Approx. market value
45.71K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
45.71KTotal acquired45.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 45.71K | — |
| Total | 45.71K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
45.71K
Market value
$834.6K
4/27/2026
Total
Units
45.71K
Value
$834.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/27/2026 | 45.71K | $834.6K | Nasdaq | Planned |
| Total | 45.71K | $834.6K | ||